-
1
-
-
77957994659
-
Multiple defects in energy metabolism in Alzheimer's disease
-
Ferreira, I. L.; Resende, R.; Ferreiro, E.; Rego, A. C.; Pereira, C. F. Multiple defects in energy metabolism in Alzheimer's disease Curr. Drug Targets 2010, 11, 1193-1206
-
(2010)
Curr. Drug Targets
, vol.11
, pp. 1193-1206
-
-
Ferreira, I.L.1
Resende, R.2
Ferreiro, E.3
Rego, A.C.4
Pereira, C.F.5
-
2
-
-
36549083642
-
Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease
-
Rojo, L. E.; Fernandez, J. A.; Maccioni, A. A.; Jimenez, J. M.; Maccioni, R. B. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease Arch Med. Res. 2008, 39, 1-16
-
(2008)
Arch Med. Res.
, vol.39
, pp. 1-16
-
-
Rojo, L.E.1
Fernandez, J.A.2
Maccioni, A.A.3
Jimenez, J.M.4
Maccioni, R.B.5
-
3
-
-
84878638145
-
Alterations in metabolic pathways and networks in Alzheimer's disease
-
Kaddurah-Daouk, R.; Zhu, H.; Sharma, S.; Bogdanov, M.; Rozen, S. G.; Matson, W.; Oki, N. O.; Motsinger-Reif, A. A.; Churchill, E.; Lei, Z.; Appleby, D.; Kling, M. A.; Trojanowski, J. Q.; Doraiswamy, P. M.; Arnold, S. E. Alterations in metabolic pathways and networks in Alzheimer's disease Transl. Psychiatry 2013, 3, e244
-
(2013)
Transl. Psychiatry
, vol.3
, pp. 244
-
-
Kaddurah-Daouk, R.1
Zhu, H.2
Sharma, S.3
Bogdanov, M.4
Rozen, S.G.5
Matson, W.6
Oki, N.O.7
Motsinger-Reif, A.A.8
Churchill, E.9
Lei, Z.10
Appleby, D.11
Kling, M.A.12
Trojanowski, J.Q.13
Doraiswamy, P.M.14
Arnold, S.E.15
-
4
-
-
69149095731
-
Early diagnosis of Alzheimer's disease: Is MCI too late?
-
Petersen, R. C. Early diagnosis of Alzheimer's disease: is MCI too late? Curr. Alzheimer Res. 2009, 6, 324-330
-
(2009)
Curr. Alzheimer Res.
, vol.6
, pp. 324-330
-
-
Petersen, R.C.1
-
5
-
-
84876399058
-
Biomarkers of Alzheimer disease: Current and future applications to diagnostic criteria
-
Sperling, R.; Johnson, K. Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria Continuum 2013, 19, 325-338
-
(2013)
Continuum
, vol.19
, pp. 325-338
-
-
Sperling, R.1
Johnson, K.2
-
6
-
-
84861910849
-
Serial CSF sampling in Alzheimer's disease: Specific versus non-specific markers
-
Kester, M. I.; Scheffer, P. G.; Koel-Simmelink, M. J.; Twaalfhoven, H.; Verwey, N. A.; Veerhuis, R.; Twisk, J. W.; Bouwman, F. H.; Blankenstein, M. A.; Scheltens, P.; Teunissen, C.; van der Flier, W. M. Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers Neurobiol. Aging 2012, 33, 1591-1598
-
(2012)
Neurobiol. Aging
, vol.33
, pp. 1591-1598
-
-
Kester, M.I.1
Scheffer, P.G.2
Koel-Simmelink, M.J.3
Twaalfhoven, H.4
Verwey, N.A.5
Veerhuis, R.6
Twisk, J.W.7
Bouwman, F.H.8
Blankenstein, M.A.9
Scheltens, P.10
Teunissen, C.11
Van Der Flier, W.M.12
-
7
-
-
84871407901
-
Metabolomics: A novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease
-
Xu, X. H.; Huang, Y.; Wang, G.; Chen, S. D. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease Neurosci. Bull. 2012, 28, 641-648
-
(2012)
Neurosci. Bull.
, vol.28
, pp. 641-648
-
-
Xu, X.H.1
Huang, Y.2
Wang, G.3
Chen, S.D.4
-
8
-
-
78049416309
-
Analytical approaches to metabolomics and applications to systems biology
-
Wang, J. H.; Byun, J.; Pennathur, S. Analytical approaches to metabolomics and applications to systems biology Semin. Nephrol. 2010, 30, 500-511
-
(2010)
Semin. Nephrol.
, vol.30
, pp. 500-511
-
-
Wang, J.H.1
Byun, J.2
Pennathur, S.3
-
9
-
-
33846000626
-
Mass spectrometry-based metabolomics
-
Dettmer, K.; Aronov, P. A.; Hammock, B. D. Mass spectrometry-based metabolomics Mass Spectrom. Rev. 2007, 26, 51-78
-
(2007)
Mass Spectrom. Rev.
, vol.26
, pp. 51-78
-
-
Dettmer, K.1
Aronov, P.A.2
Hammock, B.D.3
-
10
-
-
84877111087
-
Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease
-
10.1186/1476-511X-12-68
-
Tajima, Y.; Ishikawa, M.; Maekawa, K.; Murayama, M.; Senoo, Y.; Nishimaki-Mogami, T.; Nakanishi, H.; Ikeda, K.; Arita, M.; Taguchi, R.; Okuno, A.; Mikawa, R.; Niida, S.; Takikawa, O.; Saito, Y. Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease Lipids Health Dis 2013, 12 10.1186/1476-511X-12-68
-
(2013)
Lipids Health Dis
, vol.12
-
-
Tajima, Y.1
Ishikawa, M.2
Maekawa, K.3
Murayama, M.4
Senoo, Y.5
Nishimaki-Mogami, T.6
Nakanishi, H.7
Ikeda, K.8
Arita, M.9
Taguchi, R.10
Okuno, A.11
Mikawa, R.12
Niida, S.13
Takikawa, O.14
Saito, Y.15
-
11
-
-
84881402835
-
Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease
-
Iuliano, L.; Pacelli, A.; Ciacciarelli, M.; Zerbinati, C.; Fagioli, S.; Piras, F.; Orfei, M. D.; Bossu, P.; Pazzelli, F.; Serviddio, G.; Caltagirone, C.; Spalletta, G. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease J. Alzheimers Dis. 2013, 36, 545-53
-
(2013)
J. Alzheimers Dis.
, vol.36
, pp. 545-553
-
-
Iuliano, L.1
Pacelli, A.2
Ciacciarelli, M.3
Zerbinati, C.4
Fagioli, S.5
Piras, F.6
Orfei, M.D.7
Bossu, P.8
Pazzelli, F.9
Serviddio, G.10
Caltagirone, C.11
Spalletta, G.12
-
12
-
-
84859374049
-
Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease
-
Cunnane, S. C.; Schneider, J. A.; Tangney, C.; Tremblay-Mercier, J.; Fortier, M.; Bennett, D. A.; Morris, M. C. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease J. Alzheimers Dis. 2012, 29, 691-697
-
(2012)
J. Alzheimers Dis.
, vol.29
, pp. 691-697
-
-
Cunnane, S.C.1
Schneider, J.A.2
Tangney, C.3
Tremblay-Mercier, J.4
Fortier, M.5
Bennett, D.A.6
Morris, M.C.7
-
13
-
-
84885424849
-
Alzheimer's disease: Amino acid levels and brain metabolic status
-
Gueli, M. C.; Taibi, G. Alzheimer's disease: amino acid levels and brain metabolic status Neurol. Sci. 2013, 34, 1575-1579
-
(2013)
Neurol. Sci.
, vol.34
, pp. 1575-1579
-
-
Gueli, M.C.1
Taibi, G.2
-
14
-
-
50849141305
-
A multi-metabolite analysis of serum by 1H NMR spectroscopy: Early systemic signs of Alzheimer's disease
-
Tukiainen, T.; Tynkkynen, T.; Makinen, V. P.; Jylanki, P.; Kangas, A.; Hokkanen, J.; Vehtari, A.; Grohn, O.; Hallikainen, M.; Soininen, H.; Kivipelto, M.; Groop, P. H.; Kaski, K.; Laatikainen, R.; Soininen, P.; Pirttila, T.; Ala-Korpela, M. A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease Biochem. Biophys. Res. Commun. 2008, 375, 356-361
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.375
, pp. 356-361
-
-
Tukiainen, T.1
Tynkkynen, T.2
Makinen, V.P.3
Jylanki, P.4
Kangas, A.5
Hokkanen, J.6
Vehtari, A.7
Grohn, O.8
Hallikainen, M.9
Soininen, H.10
Kivipelto, M.11
Groop, P.H.12
Kaski, K.13
Laatikainen, R.14
Soininen, P.15
Pirttila, T.16
Ala-Korpela, M.17
-
15
-
-
4644304936
-
Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients
-
Walter, A.; Korth, U.; Hilgert, M.; Hartmann, J.; Weichel, O.; Fassbender, K.; Schmitt, A.; Klein, J. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients Neurobiol. Aging 2004, 25, 1299-1303
-
(2004)
Neurobiol. Aging
, vol.25
, pp. 1299-1303
-
-
Walter, A.1
Korth, U.2
Hilgert, M.3
Hartmann, J.4
Weichel, O.5
Fassbender, K.6
Schmitt, A.7
Klein, J.8
-
16
-
-
84878638145
-
Alterations in metabolic pathways and networks in Alzheimer's disease
-
10.1038/tp.2013.18
-
Kaddurah-Daouk, R.; Zhu, H.; Sharma, S.; Bogdanov, M.; Rozen, S. G.; Matson, W.; Oki, N. O.; Motsinger-Reif, A. A.; Churchill, E.; Lei, Z.; Appleby, D.; Kling, M. A.; Trojanowski, J. Q.; Doraiswamy, P. M.; Arnold, S. E. Alterations in metabolic pathways and networks in Alzheimer's disease Transl. Psychiatry 2013, 3 10.1038/tp.2013.18
-
(2013)
Transl. Psychiatry
, vol.3
-
-
Kaddurah-Daouk, R.1
Zhu, H.2
Sharma, S.3
Bogdanov, M.4
Rozen, S.G.5
Matson, W.6
Oki, N.O.7
Motsinger-Reif, A.A.8
Churchill, E.9
Lei, Z.10
Appleby, D.11
Kling, M.A.12
Trojanowski, J.Q.13
Doraiswamy, P.M.14
Arnold, S.E.15
-
17
-
-
83755180492
-
Metabolome in progression to Alzheimer's disease
-
10.1038/tp.2011.55
-
Oresic, M.; Hyotylainen, T.; Herukka, S. K.; Sysi-Aho, M.; Mattila, I.; Seppanan-Laakso, T.; Julkunen, V.; Gopalacharyulu, P. V.; Hallikainen, M.; Koikkalainen, J.; Kivipelto, M.; Helisalmi, S.; Lotjonen, J.; Soininen, H. Metabolome in progression to Alzheimer's disease Transl. Psychiatry 2011, 1 10.1038/tp.2011.55
-
(2011)
Transl. Psychiatry
, vol.1
-
-
Oresic, M.1
Hyotylainen, T.2
Herukka, S.K.3
Sysi-Aho, M.4
Mattila, I.5
Seppanan-Laakso, T.6
Julkunen, V.7
Gopalacharyulu, P.V.8
Hallikainen, M.9
Koikkalainen, J.10
Kivipelto, M.11
Helisalmi, S.12
Lotjonen, J.13
Soininen, H.14
-
18
-
-
65949120933
-
A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
-
Greenberg, N.; Grassano, A.; Thambisetty, M.; Lovestone, S.; Legido-Quigley, C. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease Electrophoresis 2009, 30, 1235-1239
-
(2009)
Electrophoresis
, vol.30
, pp. 1235-1239
-
-
Greenberg, N.1
Grassano, A.2
Thambisetty, M.3
Lovestone, S.4
Legido-Quigley, C.5
-
19
-
-
84877888815
-
Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics
-
Trushina, E.; Dutta, T.; Persson, X. M.; Mielke, M. M.; Petersen, R. C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics PLoS One 2013, 8, e63644
-
(2013)
PLoS One
, vol.8
, pp. 63644
-
-
Trushina, E.1
Dutta, T.2
Persson, X.M.3
Mielke, M.M.4
Petersen, R.C.5
-
20
-
-
78649706772
-
Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry
-
Sato, Y.; Nakamura, T.; Aoshima, K.; Oda, Y. Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry Anal. Chem. 2010, 82, 9858-9864
-
(2010)
Anal. Chem.
, vol.82
, pp. 9858-9864
-
-
Sato, Y.1
Nakamura, T.2
Aoshima, K.3
Oda, Y.4
-
21
-
-
84863254027
-
Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology
-
Sato, Y.; Suzuki, I.; Nakamura, T.; Bernier, F.; Aoshima, K.; Oda, Y. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology J. Lipid Res. 2012, 53, 567-576
-
(2012)
J. Lipid Res.
, vol.53
, pp. 567-576
-
-
Sato, Y.1
Suzuki, I.2
Nakamura, T.3
Bernier, F.4
Aoshima, K.5
Oda, Y.6
-
22
-
-
79960114429
-
Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics
-
Han, X.; Rozen, S.; Boyle, S. H.; Hellegers, C.; Cheng, H.; Burke, J. R.; Welsh-Bohmer, K. A.; Doraiswamy, P. M.; Kaddurah-Daouk, R. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics PLoS One 2011, 6, e21643
-
(2011)
PLoS One
, vol.6
, pp. 21643
-
-
Han, X.1
Rozen, S.2
Boyle, S.H.3
Hellegers, C.4
Cheng, H.5
Burke, J.R.6
Welsh-Bohmer, K.A.7
Doraiswamy, P.M.8
Kaddurah-Daouk, R.9
-
23
-
-
0023833603
-
The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
-
Tierney, M. C.; Fisher, R. H.; Lewis, A. J.; Zorzitto, M. L.; Snow, W. G.; Reid, D. W.; Nieuwstraten, P. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases Neurology 1988, 38, 359-364
-
(1988)
Neurology
, vol.38
, pp. 359-364
-
-
Tierney, M.C.1
Fisher, R.H.2
Lewis, A.J.3
Zorzitto, M.L.4
Snow, W.G.5
Reid, D.W.6
Nieuwstraten, P.7
-
24
-
-
0032988610
-
Mild cognitive impairment: Clinical characterization and outcome
-
Petersen, R. C.; Smith, G. E.; Waring, S. C.; Ivnik, R. J.; Tangalos, E. G.; Kokmen, E. Mild cognitive impairment: clinical characterization and outcome Arch Neurol 1999, 56, 303-308
-
(1999)
Arch Neurol
, vol.56
, pp. 303-308
-
-
Petersen, R.C.1
Smith, G.E.2
Waring, S.C.3
Ivnik, R.J.4
Tangalos, E.G.5
Kokmen, E.6
-
25
-
-
0030870822
-
Improved method for genotyping apolipoprotein e polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes
-
Zivelin, A.; Rosenberg, N.; Peretz, H.; Amit, Y.; Kornbrot, N.; Seligsohn, U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes Clin Chem. 1997, 43, 1657-1659
-
(1997)
Clin Chem.
, vol.43
, pp. 1657-1659
-
-
Zivelin, A.1
Rosenberg, N.2
Peretz, H.3
Amit, Y.4
Kornbrot, N.5
Seligsohn, U.6
-
26
-
-
70350028279
-
Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS
-
Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8, 4844-4850
-
(2009)
J. Proteome Res.
, vol.8
, pp. 4844-4850
-
-
Qiu, Y.1
Cai, G.2
Su, M.3
Chen, T.4
Zheng, X.5
Xu, Y.6
Ni, Y.7
Zhao, A.8
Xu, L.X.9
Cai, S.10
Jia, W.11
-
27
-
-
84887247737
-
Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE epsilon4 allele
-
Chouinard-Watkins, R.; Rioux-Perreault, C.; Fortier, M.; Tremblay-Mercier, J.; Zhang, Y.; Lawrence, P.; Vohl, M. C.; Perron, P.; Lorrain, D.; Brenna, J. T.; Cunnane, S. C.; Plourde, M. Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE epsilon4 allele Br. J. Nutr. 2013, 1-9
-
(2013)
Br. J. Nutr.
, pp. 1-9
-
-
Chouinard-Watkins, R.1
Rioux-Perreault, C.2
Fortier, M.3
Tremblay-Mercier, J.4
Zhang, Y.5
Lawrence, P.6
Vohl, M.C.7
Perron, P.8
Lorrain, D.9
Brenna, J.T.10
Cunnane, S.C.11
Plourde, M.12
-
28
-
-
84871291341
-
Potential metabolite markers of schizophrenia
-
Yang, J.; Chen, T.; Sun, L.; Zhao, Z.; Qi, X.; Zhou, K.; Cao, Y.; Wang, X.; Qiu, Y.; Su, M.; Zhao, A.; Wang, P.; Yang, P.; Wu, J.; Feng, G.; He, L.; Jia, W.; Wan, C. Potential metabolite markers of schizophrenia Mol. Psychiatry 2013, 18, 67-78
-
(2013)
Mol. Psychiatry
, vol.18
, pp. 67-78
-
-
Yang, J.1
Chen, T.2
Sun, L.3
Zhao, Z.4
Qi, X.5
Zhou, K.6
Cao, Y.7
Wang, X.8
Qiu, Y.9
Su, M.10
Zhao, A.11
Wang, P.12
Yang, P.13
Wu, J.14
Feng, G.15
He, L.16
Jia, W.17
Wan, C.18
-
29
-
-
42249103252
-
Fatty acids, lipid metabolism and Alzheimer pathology
-
Hooijmans, C. R.; Kiliaan, A. J. Fatty acids, lipid metabolism and Alzheimer pathology Eur. J. Pharmacol. 2008, 585, 176-196
-
(2008)
Eur. J. Pharmacol.
, vol.585
, pp. 176-196
-
-
Hooijmans, C.R.1
Kiliaan, A.J.2
-
30
-
-
84880301389
-
N-3 Fatty Acids: Role in Neurogenesis and Neuroplasticity
-
Crupi, R.; Marino, A.; Cuzzocrea, S. n-3 Fatty Acids: Role in Neurogenesis and Neuroplasticity Curr. Med. Chem. 2013, 20, 2953-2963
-
(2013)
Curr. Med. Chem.
, vol.20
, pp. 2953-2963
-
-
Crupi, R.1
Marino, A.2
Cuzzocrea, S.3
-
31
-
-
84863575318
-
Nutrient intake and plasma beta-amyloid
-
Gu, Y.; Schupf, N.; Cosentino, S. A.; Luchsinger, J. A.; Scarmeas, N. Nutrient intake and plasma beta-amyloid Neurology 2012, 78, 1832-1840
-
(2012)
Neurology
, vol.78
, pp. 1832-1840
-
-
Gu, Y.1
Schupf, N.2
Cosentino, S.A.3
Luchsinger, J.A.4
Scarmeas, N.5
-
32
-
-
56449118242
-
Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease
-
Rapoport, S. I. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease Prostaglandins, Leukotrienes Essent. Fatty Acids 2008, 79, 153-156
-
(2008)
Prostaglandins, Leukotrienes Essent. Fatty Acids
, vol.79
, pp. 153-156
-
-
Rapoport, S.I.1
-
33
-
-
84864842688
-
Serum fatty-acid composition and the risk of Alzheimer's disease: A longitudinal population-based study
-
Ronnemaa, E.; Zethelius, B.; Vessby, B.; Lannfelt, L.; Byberg, L.; Kilander, L. Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study Eur. J. Clin Nutr 2012, 66, 885-890
-
(2012)
Eur. J. Clin Nutr
, vol.66
, pp. 885-890
-
-
Ronnemaa, E.1
Zethelius, B.2
Vessby, B.3
Lannfelt, L.4
Byberg, L.5
Kilander, L.6
-
34
-
-
33845505233
-
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
-
Sun, X.; He, G.; Qing, H.; Zhou, W.; Dobie, F.; Cai, F.; Staufenbiel, M.; Huang, L. E.; Song, W. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 18727-18732
-
(2006)
Proc. Natl. Acad. Sci. U.S.A.
, vol.103
, pp. 18727-18732
-
-
Sun, X.1
He, G.2
Qing, H.3
Zhou, W.4
Dobie, F.5
Cai, F.6
Staufenbiel, M.7
Huang, L.E.8
Song, W.9
-
35
-
-
77952549255
-
Pathological role of hypoxia in Alzheimer's disease
-
Zhang, X.; Le, W. Pathological role of hypoxia in Alzheimer's disease Exp. Neurol. 2010, 223, 299-303
-
(2010)
Exp. Neurol.
, vol.223
, pp. 299-303
-
-
Zhang, X.1
Le, W.2
-
36
-
-
70449397210
-
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
-
Carvalho, C.; Correia, S. C.; Santos, R. X.; Cardoso, S.; Moreira, P. I.; Clark, T. A.; Zhu, X.; Smith, M. A.; Perry, G. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia J. Bioenerg. Biomembr. 2009, 41, 433-440
-
(2009)
J. Bioenerg. Biomembr.
, vol.41
, pp. 433-440
-
-
Carvalho, C.1
Correia, S.C.2
Santos, R.X.3
Cardoso, S.4
Moreira, P.I.5
Clark, T.A.6
Zhu, X.7
Smith, M.A.8
Perry, G.9
-
37
-
-
84867716087
-
Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease
-
Garcia-Garcia, A.; Zavala-Flores, L.; Rodriguez-Rocha, H.; Franco, R. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease Antioxid. Redox Signaling 2012, 17, 1764-1784
-
(2012)
Antioxid. Redox Signaling
, vol.17
, pp. 1764-1784
-
-
Garcia-Garcia, A.1
Zavala-Flores, L.2
Rodriguez-Rocha, H.3
Franco, R.4
-
38
-
-
18844462415
-
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease
-
Wang, J.; Xiong, S.; Xie, C.; Markesbery, W. R.; Lovell, M. A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease J. Neurochem. 2005, 93, 953-962
-
(2005)
J. Neurochem.
, vol.93
, pp. 953-962
-
-
Wang, J.1
Xiong, S.2
Xie, C.3
Markesbery, W.R.4
Lovell, M.A.5
-
39
-
-
34249786877
-
Glutamine in the central nervous system: Function and dysfunction
-
Albrecht, J.; Sonnewald, U.; Waagepetersen, H. S.; Schousboe, A. Glutamine in the central nervous system: function and dysfunction Front. Biosci. 2007, 12, 332-343
-
(2007)
Front. Biosci.
, vol.12
, pp. 332-343
-
-
Albrecht, J.1
Sonnewald, U.2
Waagepetersen, H.S.3
Schousboe, A.4
-
40
-
-
84872191631
-
The cystine/glutamate antiporter system x(c)(-) in health and disease: From molecular mechanisms to novel therapeutic opportunities
-
Lewerenz, J.; Hewett, S. J.; Huang, Y.; Lambros, M.; Gout, P. W.; Kalivas, P. W.; Massie, A.; Smolders, I.; Methner, A.; Pergande, M.; Smith, S. B.; Ganapathy, V.; Maher, P. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities Antioxid. Redox Signaling 2013, 18, 522-555
-
(2013)
Antioxid. Redox Signaling
, vol.18
, pp. 522-555
-
-
Lewerenz, J.1
Hewett, S.J.2
Huang, Y.3
Lambros, M.4
Gout, P.W.5
Kalivas, P.W.6
Massie, A.7
Smolders, I.8
Methner, A.9
Pergande, M.10
Smith, S.B.11
Ganapathy, V.12
Maher, P.13
-
41
-
-
36348970691
-
Proline promotes decrease in glutamate uptake in slices of cerebral cortex and hippocampus of rats
-
Delwing, D.; Sanna, R. J.; Wofchuk, S.; Wyse, A. T. Proline promotes decrease in glutamate uptake in slices of cerebral cortex and hippocampus of rats Life Sci. 2007, 81, 1645-1650
-
(2007)
Life Sci.
, vol.81
, pp. 1645-1650
-
-
Delwing, D.1
Sanna, R.J.2
Wofchuk, S.3
Wyse, A.T.4
-
42
-
-
34249816781
-
2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: Effects of diabetes, renal failure and sepsis
-
Sell, D. R.; Strauch, C. M.; Shen, W.; Monnier, V. M. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis Biochem. J. 2007, 404, 269-277
-
(2007)
Biochem. J.
, vol.404
, pp. 269-277
-
-
Sell, D.R.1
Strauch, C.M.2
Shen, W.3
Monnier, V.M.4
-
43
-
-
84881510899
-
Application of artificial neural networks to investigate one-carbon metabolism in Alzheimer's disease and healthy matched individuals
-
Coppede, F.; Grossi, E.; Buscema, M.; Migliore, L. Application of artificial neural networks to investigate one-carbon metabolism in Alzheimer's disease and healthy matched individuals PLoS One 2013, 8, e74012
-
(2013)
PLoS One
, vol.8
, pp. 74012
-
-
Coppede, F.1
Grossi, E.2
Buscema, M.3
Migliore, L.4
-
44
-
-
84873713502
-
High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS
-
Midttun, O.; Kvalheim, G.; Ueland, P. M. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS Anal. Bioanal. Chem. 2013, 405, 2009-2017
-
(2013)
Anal. Bioanal. Chem.
, vol.405
, pp. 2009-2017
-
-
Midttun, O.1
Kvalheim, G.2
Ueland, P.M.3
-
45
-
-
84903154904
-
Recent advances in the application of metabolomics to Alzheimer's Disease
-
10.1016/j.bbadis.2013.06.014
-
Trushina, E.; Mielke, M. M. Recent advances in the application of metabolomics to Alzheimer's Disease Biochim. Biophys. Acta 2013, 10.1016/j.bbadis.2013.06.014
-
(2013)
Biochim. Biophys. Acta
-
-
Trushina, E.1
Mielke, M.M.2
|